Cafepharma Today

January 17 2025 - Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
AstraZeneca overhauls management of its scandal-hit China division
Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
Ozempic tops new Medicare price negotiation list
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Xoma diabetes studies could lead to single monthly dose
Bizjournals.com
Monday, September 8, 2008 - 3:27pm
tags:
Biodel Sinks on Mixed Drug Study Results
The Street.com
Monday, September 8, 2008 - 3:26pm
tags:
Medivation's Attitude Warrants a Pullback
Seeking Alpha
Monday, September 8, 2008 - 3:24pm
tags:
FDA advisers say Pfizer drug would benefit some women with osteoporosis, despite risks
Yahoo/AP
Monday, September 8, 2008 - 3:23pm
tags:
Bristol-Myers and AstraZeneca say diabetes drug met objectives in 2 late-stage trials
Yahoo/AP
Monday, September 8, 2008 - 3:22pm
tags:
Glaxo's Viehbacher to leave after missing CEO job
Forbes
Monday, September 8, 2008 - 11:57am
tags:
Another FDA Safety Warning (Yawn.)
Motley Fool
Monday, September 8, 2008 - 11:42am
tags:
Biodel says Viaject met goals in diabetes trial, but India data sends stock to all-time low
Yahoo/AP
Monday, September 8, 2008 - 11:39am
tags:
Fannie, Freddie & Pharma: Resolution "Helps" Sector Stocks?
CNBC
Monday, September 8, 2008 - 11:38am
tags:
Medarex Receives Milestone Payment From Pfizer on IND Filing
Cafepharma Detailpiece
Monday, September 8, 2008 - 10:54am
tags:
Elan seeks second-round bids for €1bn EDT drug unit
Independent, Ireland
Monday, September 8, 2008 - 10:18am
tags:
Analyst's Comments Buoy PFE
Market Intelligence Center
Monday, September 8, 2008 - 10:09am
tags:
AMRI to receive $1.5M from Bristol-Myers
Bizjournals.com
Monday, September 8, 2008 - 10:07am
tags:
AstraZeneca says Saxagliptin improved glucose control
Marketwatch
Monday, September 8, 2008 - 9:09am
tags:
J&J Seeks Expanded U.S. Use of Doxil in Breast Cancer
Bloomberg
Monday, September 8, 2008 - 9:08am
tags:
Bristol, Astra diabetes pill promising in studies
Reuters
Monday, September 8, 2008 - 9:07am
tags:
Novo Nordisk: phase 3 study of liraglutide showed benefits
Marketwatch
Monday, September 8, 2008 - 9:06am
tags:
5 Big Pharma Cash Machines
Seeking Alpha
Monday, September 8, 2008 - 9:04am
tags:
Healthcare's Low Elasticity Pays Off
Seeking Alpha
Monday, September 8, 2008 - 9:04am
tags:
Pfizer to Pitch Treatment For Osteoporosis to FDA Panel
WSJ Online
Monday, September 8, 2008 - 9:02am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information